Loading
Latest filing published 21 Jun 2022 for Vaxxinity, Inc.. Read the official filing
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
This profile gathers the share dealings of United Biomedical Inc in Vaxxinity, Inc. The record holds 5 filings, for trades running from 15 November 2021 to 16 June 2022.
No open-market sale appears; the market trades are 4 purchases. The totals do not cover 4 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2022 to date brings 4 purchases and no sales.
The latest filing, published on 21 June 2022, reports an open-market purchase in Vaxxinity, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations